Haemonetics (HAE) Tops Q2 EPS by 5c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall St dips after AI-led selloff; SpaceX worries hit telecoms
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude hits more than five-month high on Houthi-Saudi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $116.49 +0.28%
EPS Growth %: +1.6%
Financial Fact:
Net revenues: 220.25M
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
EPS Growth %: +1.6%
Financial Fact:
Net revenues: 220.25M
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Join SI Premium – FREE
Haemonetics (NYSE: HAE) reported Q2 EPS of $0.44, $0.05 better than the analyst estimate of $0.39. Revenue for the quarter came in at $219.7 million versus the consensus estimate of $226.5 million.
For earnings history and earnings-related data on Haemonetics (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meta's capital-raising plans expose a major weakness in the AI boom
- Infosys Limited (INFY) Reports In-Line Q3 EPS
- Sallie Mae falls on earnings miss and guidance cut
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
